Genzyme expands its market for MS drug in Latin America By: Boston Business Journal via Business Journals June 30, 2014 at 13:30 PM EDT Genzyme’s drug to treat adult patients with multiple sclerosis has received approval by yet another agency outside the U... Read More >> Related Stocks: Sanofi-Aventis S.A. ADR